Compare · AIRS vs LFST
AIRS vs LFST
Side-by-side comparison of AirSculpt Technologies Inc. (AIRS) and LifeStance Health Group Inc. (LFST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AIRS and LFST operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- LFST is the larger of the two at $4.82B, about 25.6x AIRS ($188.2M).
- LFST has hit the wire 8 times in the past 4 weeks while AIRS has been quiet.
- LFST has more recent analyst coverage (17 ratings vs 8 for AIRS).
- Company
- AirSculpt Technologies Inc.
- LifeStance Health Group Inc.
- Price
- -
- -
- Market cap
- $188.2M
- $4.82B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2021
- News (4w)
- 0
- 8
- Recent ratings
- 8
- 17
AirSculpt Technologies Inc.
AirSculpt Technologies, Inc. focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of October 5, 2021, it operated 16 centers across 13 states. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
Latest AIRS
- Amendment: SEC Form SCHEDULE 13G/A filed by AirSculpt Technologies Inc.
- SEC Form 10-Q filed by AirSculpt Technologies Inc.
- AirSculpt Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- AirSculpt Technologies Reports Second Quarter Fiscal 2026 Results
- AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Second Quarter Fiscal 2026 Results
- AirSculpt Technologies Announces Participation in Upcoming Investor Conferences
- Director Feinstein Adam T disposed of 5,169,820 shares (SEC Form 4)
- Director Higgins Kenneth was granted 100,286 shares, increasing direct ownership by 58% to 274,066 units (SEC Form 4)
- Director Aaron Thomas J was granted 100,286 shares, increasing direct ownership by 57% to 276,866 units (SEC Form 4)
- Director Chu Caroline was granted 100,286 shares, increasing direct ownership by 57% to 277,066 units (SEC Form 4)
Latest LFST
- LifeStance Health Group Announces Pricing of Secondary Public Offering
- SEC Form 424B7 filed by LifeStance Health Group Inc.
- LifeStance Health Group Announces Launch of Secondary Public Offering
- Chief Technology Officer Paunovich Vukasin sold $541,402 worth of shares (42,067 units at $12.87), decreasing direct ownership by 17% to 205,379 units (SEC Form 4)
- Chief Executive Officer Bourdon David disposed of 150,000 shares, decreasing direct ownership by 11% to 1,248,247 units (SEC Form 4)
- LifeStance to Present at Upcoming Investor Conferences
- Chief People Officer Varanakis Ann covered exercise/tax liability with 8,156 shares, decreasing direct ownership by 2% to 413,881 units (SEC Form 4) (for withholding tax)
- Director Deluca Teresa sold $95,100 worth of shares (7,500 units at $12.68), decreasing direct ownership by 7% to 97,093 units (SEC Form 4) (withholding tax)
- Director Deluca Teresa sold $249,993 worth of shares (20,441 units at $12.23), decreasing direct ownership by 16% to 104,593 units (SEC Form 4)
- SEC Form 144 filed by LifeStance Health Group Inc.